Skip to content

A prospective study of the Effect of Intension Blood Pressure Reduction Treatment in Intracerebral Hemorrhage in the acute phase

A prospective study of the Effect of Intension Blood Pressure Reduction Treatment in Intracerebral Hemorrhage in the acute phase

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-14005622
Enrollment
Unknown
Registered
2014-12-06
Start date
2015-02-09
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracerebral Hemorrhage

Interventions

the intension blood pressure reduction group :target systolic blood pressure below 140 mmHg within 1 hour

Sponsors

the first affiliated hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. aged 65-80; 2. Supratentorial hypertensive intracerebral hemorrhage; 3. hematoma volume 10-60ml; 4. Systolic blood pressure (SBP) measuring on admission is between 200mmHg-240mmHg at least two times, and the interval must be more than or equal to 2 minutes; 5. Getting to hospital within 3 hours after the symptoms occuring, GCS more than 5 on admission; 6. being voluntary to participate this trial.

Exclusion criteria

Exclusion criteria: 1. Blood pressure is more than 240mmHg onadmission; 2. Intracranial hematoma induced by trauma; 3. Having anti-hypertension treatment contraindications; 4. Having other anti-hypertension treatment indications, and the anti-hypertension treatment target is lower or equal to this study; 5. The cerebral hemorrhage is secondary to cerebral structural abnormalities; 6. Having ischemic stroke history within 30 days; 7. Having severe dementia or disablities before; 8. Prepare for an emergency surgery; 9. Having a bleeding tendency; 10. Having delivery pregnancy or lactation within 30 days; 11. Having warfarin within 5 days; 12. PLT less than 50000/mm3; 13. Having major diseases of internal medicine, which may interfere with the outcome evaluation and follow-up (such as advanced cancer and severe respiratory disease).

Design outcomes

Primary

MeasureTime frame
Blood pressure;hematoma volume;Modified Rankin Scale, mRS;EuroQol (EQ-5D);NIH Stroke Scale, NIHSS;Glasgow Coma Scale, GCS;

Countries

China

Contacts

Public ContactXiao-pei SUN
rxrs69@sina.com+86 18641180006

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026